Positions

Selected Publications

Academic Article

Year Title Altmetric
2021 Citrullinated vimentin mediates development and progression of lung fibrosisScience Translational Medicine.  13. 2021
2019 Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation statusBlood Cancer Journal.  9. 2019
2019 Vimentin intermediate filament assembly regulates fibroblast invasion in fibrogenic lung injuryJCI insight.  4. 2019
2017 Autoimmunity to vimentin is associated with outcomes of patients with idiopathic pulmonary fibrosisJournal of Immunology.  199:1596-1605. 2017
2017 Low-dose cadmium exposure induces peribronchiolar fibrosis through site-specific phosphorylation of vimentin 2017
2016 Attenuated heme oxygenase-1 responses predispose the elderly to pulmonary nontuberculous mycobacterial infections 2016
2015 Heme oxygenase-1 protects Corexit 9500ainduced respiratory epithelial injury across speciesPLoS ONE.  10. 2015
2014 Emerging roles for the FCRL family members in lymphocyte biology and diseaseCurrent Topics in Microbiology and Immunology.  382:29-50. 2014
2013 FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiationEuropean Journal of Immunology.  43:2980-2992. 2013
2011 Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemiaBlood.  118:4902-4909. 2011
2008 FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemiaEuropean Journal of Immunology.  38:3159-3166. 2008
2008 FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemiaBlood.  112:179-187. 2008

Book

Year Title Altmetric
2014 Emerging roles for the FCRL family members in lymphocyte biology and disease.  Ed. 382.  2014

Education And Training

  • University of Alabama at Birmingham, Postdoctoral Research
  • Full Name

  • Fu Jun Li